Skip to main content
. 2019 Jan 18;39(1):BSR20181505. doi: 10.1042/BSR20181505

Table 3. Distribution of PDLIM4 polymorphisms and osteoporotic fractures risk.

SNP Case (n=540) Control (n=540) P value Crude OR (95% CI) P value Adjusted OR (95% CI)
rs77584624
TT 415 (76.9%) 424 (78.5%) 1.00 (reference)
TG 119 (22.0%) 107 (19.8%) 0.39 1.14 (0.84–1.54) 0.44 1.07 (0.91–1.22)
GG 6 (1.1%) 9 (1.7%) 0.47 0.68 (0.21–2.11) 0.64 0.81 (0.35–1.37)
TG + GG 125 (23.1%) 116 (21.5%) 0.51 1.10 (0.82–1.48) 0.56 1.05 (0.90–1.20)
TT + TG 534 (98.9%) 531 (98.3%) 1.00 (reference)
GG 6 (1.1%) 9 (1.7%) 0.44 0.66 (0.21–2.05) 0.60 0.80 (0.35–1.35)
T 949 (87.9%) 955 (88.4%) 1.00 (reference)
G 131 (12.1%) 125 (11.6%) 0.69 1.06 (0.81–1.38) 0.74 1.03 (0.89–1.16)
rs78418541
CC 403 (74.6%) 420 (77.8%) 1.00 (reference)
CT 114 (21.1%) 109 (20.2%) 0.57 1.09 (0.80–1.48) 0.62 1.04 (0.89–1.21)
TT 23 (4.3%) 11 (2.0%) 0.03 2.18 (1.00–4.83) 0.05 1.38 (1.00–1.69)
CT + TT 137 (25.4%) 120 (22.2%) 0.22 1.19 (0.89–1.59) 0.25 1.09 (0.94–1.24)
CC + CT 517 (95.7%) 529 (98.0%) 1.00 (reference)
TT 23 (4.3%) 11 (2.0%) 0.04 2.14 (0.99–4.73) 0.06 1.37 (0.99–1.67)
C 920 (85.2%) 949 (87.9%) 1.00 (reference)
T 160 (14.8%) 131 (12.1%) 0.07 1.26 (0.98–1.63) 0.08 1.12 (0.99–1.25)
rs270611
CC 265 (49.1%) 325 (60.2%) 1.00 (reference)
CA 175 (32.4%) 194 (35.9%) 0.45 1.11 (0.85–1.45) 0.49 1.06 (0.91–1.22)
AA 100 (18.5%) 21 (3.9%) <0.001 5.84 (3.47–9.92) <0.001 1.84 (1.62–2.03)
CA + AA 275 (50.9%) 215 (39.8%) <0.001 1.57 (1.22–2.01) <0.001 1.25 (1.11–1.41)
CC + CA 440 (81.5%) 519 (96.1%) 1.00 (reference)
AA 100 (18.5%) 21 (3.9%) <0.001 5.62 (3.37–9.43) <0.001 1.80 (1.60–1.96)
C 705 (65.3%) 844 (78.1%) 1.00 (reference)
A 375 (34.7%) 236 (21.9%) <0.001 1.90 (1.56–2.31) <0.001 1.34 (1.24–1.46)
rs3900945
TT 235 (43.5%) 247 (45.7%) 1.00 (reference)
TC 177 (32.8%) 224 (41.5%) 0.17 0.83 (0.63–1.09) 0.19 0.91 (0.78–1.05)
CC 128 (23.7%) 69 (12.8%) <0.001 1.95 (1.36–2.79) <0.001 1.33 (1.15–1.52)
TC + CC 305 (56.5%) 293 (54.3%) 0.46 1.09 (0.85–1.40) 0.50 1.05 (0.93–1.19)
TT + TC 412 (76.3%) 471 (87.2%) 1.00 (reference)
CC 128 (23.7%) 69 (12.8%) <0.001 2.12 (1.52–2.96) <0.001 1.39 (1.22–1.57)
T 647 (59.9%) 718 (66.5%) 1.00 (reference)
C 433 (40.1%) 362 (33.5%) <0.01 1.33 (1.11–1.59) <0.01 1.45 (1.05–1.25)
rs366512
CC 368 (68.%) 329 (60.9%) 1.00 (reference)
CT 163 (30.2%) 186 (34.4%) <0.01 0.32 (0.14–0.74) 0.01 0.50 (0.26–085)
TT 9 (1.7%) 25 (4.6%) 0.06 0.78 (0.60–1.02) 0.07 0.89 (0.77–1.01)
CT + TT 172 (31.9%) 211 (39.1%) 0.01 0.73 (0.56–0.94) 0.02 0.85 (0.74–0.97)
CC + CT 531 (98.3%) 515 (95.4%) 1.00 (reference)
TT 9 (1.7%) 25 (4.6%) <0.01 0.35 (0.15–0.79) 0.01 0.52 (0.27–0.88)
C 899 (83.2%) 844 (78.1%) 1.00 (reference)
T 181 (16.8%) 236 (21.9%) <0.01 0.72 (0.58–0.90) <0.01 0.84 (0.74–0.95)
rs77486529
AA 421(78.0%) 431(79.8%) 1.00 (reference)
AG 108 (20.0%) 101 (18.7%) 0.56 1.10 (0.80–1.50) 0.61 1.05 (0.89–1.21)
GG 11 (2.0%) 8 (1.5%) 0.47 1.41 (0.52–3.87) 0.62 1.17 (0.68–1.61)
AG + GG 119 (22.0%) 109 (20.2%) 0.46 1.12 (0.83–1.51) 0.50 1.06 (0.91–1.22)
AA + AG 529 (98.0%) 532 (98.5%) 1.00 (reference)
GG 11 (2.0%) 8 (1.5%) 0.79 1.38 (0.51–3.79) 0.64 1.16 (0.68–1.59)
A 950 (88.0%) 963 (89.2%) 1.00 (reference)
G 130 (12.0%) 117 (10.8%) 0.38 1.13 (0.86–1.48) 0.42 1.06 (0.92–1.20)
rs71583465
GG 224 (41.5%) 238 (44.1%) 1.00 (reference)
GC 234 (43.3%) 228 (42.2%) 0.51 1.09 (0.83–1.42) 0.55 1.05 (0.91–1.20)
CC 82 (15.2%) 74 (13.7%) 0.38 1.18 (0.81–1.72) 0.43 1.08 (0.89–1.29)
GC + CC 316 (58.5%) 302 (55.9%) 0.39 1.11 (0.87–1.43) 0.42 1.06 (0.93–1.20)
GG + GC 458 (84.8%) 466 (86.3%) 1.00 (reference)
CC 82 (15.2%) 74 (13.7%) 0.59 1.13 (0.79–1.61) 0.55 1.06 (0.89–1.24)
G 682 (63.1%) 704 (65.2%) 1.00 (reference)
C 398 (36.9%) 376 (34.8%) 0.32 1.09 (0.19–1.31) 0.35 1.05 (0.96–1.14)